Please login to the form below

10 Remapping the Market

Does pharma's global model need a shake up?

Digital has succeeded where armies, politics and religion have failed; taking over the world. Where once there was Alexander the Great, Augustus Caesar, Genghis Khan and Napoleon Bonaparte, we now have Mark Zuckerberg, Larry Page, Jeff Bezos and (until recently) Steve Jobs. We speak one language, adopt new behaviours, and follow the same brands. So what does this mean to pharma and its global approach to business?

The global invasion of Apple, Paypal, Instagram and others has conditioned what people have come to expect from digital experiences. They’ve set a standard that is recognised worldwide and moulded a uniformity in digital behaviours. Consider how intuitively a person can use an iPad, or the like, share and comment behaviours that are inherent in all social networks. Platforms may vary, but the means of interaction remain the same.

Line, Japan’s most popular social network , features a timeline and homepage akin to that of Facebook. 69% of internet use in Germany is via a computer, where as in Kenya usage swings dramatically towards mobile (98%). Yet in both, the average time an internet user spends online is around the 3 hour mark.

Furthermore, the digital global standard is extremely far reaching. The ‘unconnected’ global population is ever dwindling. India is experiencing 58% year-on-year growth of internet users amongst its rural communities, whilst mobile phones are a common commodity even to remote East African nomadic herders who live without regular access to electricity or running water. In such communities, digital healthcare support, however basic, is all the more valuable. It might be difficult and costly for a patient to reach the nearest healthcare professional, but if they can quickly and inexpensively seek medical advice online, or even via text or phone call, symptoms that might otherwise be ignored can be alleviated.

14th November 2014



Company Details

Havas Lynx Group

+44 (0)161 228 7756

Contact Website

52 Princess Street
M1 6JX

Latest content on this profile

THE HIDDEN LIFESAVERS: overdose prevention campaign launches nationwide
The campaign encourages people who use drugs to do something remarkable – save a life
Havas Lynx Group
Andi Goes – the children’s book that helps detect early signs of dyslexia
Havas Lynx Group have launched a children’s book aimed at raising awareness and detecting early signs of dyslexia. Helping to make sure that parents have the support they need whilst teaching from home.
Havas Lynx Group
Neurofibromatosis: a condition that’s hard to say, but even harder to live with
The Childhood Tumour Trust and Havas Lynx Group have launched a campaign to raise awareness and funds for people living with a rare genetic condition, neurofibromatosis 1 (NF1).
Havas Lynx Group
Havas Health & You Launches Behind the Mask, a Global Research Initiative to Document Health Experiences During the COVID-19 Pandemic and Beyond
Havas Health & You (HH&Y) have launched the details of a long-term global research project, Behind the Mask, a longitudinal, multi-armed study which focuses on documenting the ongoing evolution of health and wellness.
Havas Lynx Group
Media Means Business
Creating meaningful media experiences in pharma
Havas Lynx Group
Havas Lynx Group elevates Jon Chapman and Paul Kinsella to CCOs
Havas Lynx Group announces the promotion of Jon Chapman and Paul Kinsella from Executive Creative Directors (ECD) to Chief Creative Officers (CCO) for Havas Lynx Group.
Havas Lynx Group